The COLO320 line was chosen as it is also one of the few available colorectal cancer cell lines via ATCC that is derived from a female patient and positive for the prolactin receptor, allowing us to explore the phosphorylation of STAT3 in response to prolactin treatment. This evidence concerns the gene PRLR and colorectal cancer.